CD27 and cancer: New insights into the tumor progressive role of CD70 further strengthen the rationale of exploiting CD70 in cancer patients, having the potential to (1) specifically eliminate the CD70 expressing cancer cell populations and (2) abrogate the tumor promoting mechanisms by the CD70-CD27 signaling axis, both in early stage and advanced disease.